Savient's Krystexxa Wins Advisory Cmte. Endorsement

In light of a cardiovascular signal but insufficient data, panel recommends a REMS with provider registration for the orphan biologic.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet